Literature DB >> 28005463

CDK regulation of transcription by RNAP II: Not over 'til it's over?

Robert P Fisher1.   

Abstract

Transcription by RNA polymerase (RNAP) II is regulated at multiple steps by phosphorylation, catalyzed mainly by members of the cyclin-dependent kinase (CDK) family. The CDKs involved in transcription have overlapping substrate specificities, but play largely non-redundant roles in coordinating gene expression. Novel functions and targets of CDKs have recently emerged at the end of the transcription cycle, when the primary transcript is cleaved, and in most cases polyadenylated, and transcription is terminated by the action of the "torpedo" exonuclease Xrn2, which is a CDK substrate. Collectively, various functions have been ascribed to CDKs or CDK-mediated phosphorylation: recruiting cleavage and polyadenylation factors, preventing premature termination within gene bodies while promoting efficient termination of full-length transcripts, and preventing extensive readthrough transcription into intergenic regions or neighboring genes. The assignment of precise functions to specific CDKs is still in progress, but recent advances suggest ways in which the CDK network and RNAP II machinery might cooperate to ensure timely exit from the transcription cycle.

Entities:  

Keywords:  C-terminal domain; cleavage and polyadenylation; Cyclin-dependent kinase; positive transcription elongation factor b; protein phosphorylation; RNA polymerase II; RNA processing; transcription termination; Xrn2

Mesh:

Substances:

Year:  2016        PMID: 28005463      PMCID: PMC5423476          DOI: 10.1080/21541264.2016.1268244

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  73 in total

1.  Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.

Authors:  Y Ramanathan; S M Rajpara; S M Reza; E Lees; S Shuman; M B Mathews; T Pe'ery
Journal:  J Biol Chem       Date:  2001-01-16       Impact factor: 5.157

2.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.

Authors:  Stéphane Larochelle; Karl A Merrick; Marie-Emilie Terret; Lara Wohlbold; Nora M Barboza; Chao Zhang; Kevan M Shokat; Prasad V Jallepalli; Robert P Fisher
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

Review 3.  Formation of the 3' end of histone mRNA: getting closer to the end.

Authors:  Zbigniew Dominski; William F Marzluff
Journal:  Gene       Date:  2007-05-04       Impact factor: 3.688

4.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

Review 5.  The super elongation complex (SEC) family in transcriptional control.

Authors:  Zhuojuan Luo; Chengqi Lin; Ali Shilatifard
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

6.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.

Authors:  Camilla L Christensen; Nicholas Kwiatkowski; Brian J Abraham; Julian Carretero; Fatima Al-Shahrour; Tinghu Zhang; Edmond Chipumuro; Grit S Herter-Sprie; Esra A Akbay; Abigail Altabef; Jianming Zhang; Takeshi Shimamura; Marzia Capelletti; Jakob B Reibel; Jillian D Cavanaugh; Peng Gao; Yan Liu; Signe R Michaelsen; Hans S Poulsen; Amir R Aref; David A Barbie; James E Bradner; Rani E George; Nathanael S Gray; Richard A Young; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

7.  Defining the status of RNA polymerase at promoters.

Authors:  Leighton J Core; Joshua J Waterfall; Daniel A Gilchrist; David C Fargo; Hojoong Kwak; Karen Adelman; John T Lis
Journal:  Cell Rep       Date:  2012-10-10       Impact factor: 9.423

Review 8.  Progression through the RNA polymerase II CTD cycle.

Authors:  Stephen Buratowski
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

9.  CDK7-dependent transcriptional addiction in triple-negative breast cancer.

Authors:  Yubao Wang; Tinghu Zhang; Nicholas Kwiatkowski; Brian J Abraham; Tong Ihn Lee; Shaozhen Xie; Haluk Yuzugullu; Thanh Von; Heyuan Li; Ziao Lin; Daniel G Stover; Elgene Lim; Zhigang C Wang; J Dirk Iglehart; Richard A Young; Nathanael S Gray; Jean J Zhao
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

10.  3' end formation of pre-mRNA and phosphorylation of Ser2 on the RNA polymerase II CTD are reciprocally coupled in human cells.

Authors:  Lee Davidson; Lisa Muniz; Steven West
Journal:  Genes Dev       Date:  2014-01-29       Impact factor: 11.361

View more
  2 in total

1.  CDK7 is a component of the integrated stress response regulating SNAT2 (SLC38A2)/System A adaptation in response to cellular amino acid deprivation.

Authors:  Clare Stretton; Christopher Lipina; Russell Hyde; Emma Cwiklinski; Thorsten M Hoffmann; Peter M Taylor; Harinder S Hundal
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-03-08       Impact factor: 4.739

Review 2.  Therapeutic targeting of transcriptional cyclin-dependent kinases.

Authors:  Matthew D Galbraith; Heather Bender; Joaquín M Espinosa
Journal:  Transcription       Date:  2018-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.